Loss of caspase-8 in tumor cells: Mechanism to overcome integrin-mediated death?

Molecular Interventions

Volumn 6, Issue 3, 2006, Pages 132-136

  Podgorski, Izabela ^a   Sloane, Bonnie F ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NCI Cancer Imaging Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; CYCLOHEXIMIDE; ETOPOSIDE; INTEGRIN RECEPTOR; STAUROSPORINE;

APOPTOSIS; CELL FUNCTION; CELL INTERACTION; CELL SURVIVAL; DRUG ANTAGONISM; DRUG MECHANISM; HUMAN; METASTASIS; MICROENVIRONMENT; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PROTEIN DEPLETION; SHORT SURVEY; TUMOR CELL; TUMOR GROWTH;

APOPTOSIS; CASPASE 8; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INTEGRINS; NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 33745684335     PISSN: 15340384     EISSN: None     Source Type: Journal    
DOI: 10.1124/mi.6.3.3     Document Type: Short Survey

References (38)

1. Cahill, D.P., Kinzler, K.W., Vogelstein, B., and Lengauer, C. Genetic instability and darwinian selection in tumours. Trends Cell Biol. 9, M57-M60 (1999).
2. Stupack, D.G. and Cheresh, D.A. Get a ligand, get a life: Integrins, signaling and cell survival. J. Cell Sci. 115, 3729-3738 (2002).
3. Miranti, C.K. and Brugge, J.S. Sensing the environment: A historical perspective on integrin signal transduction. Nat. Cell Biol. 4, E83-E90 (2002).
4. Hanahan, D. and Weinberg, R.A. The hallmarks of cancer. Cell 100, 57-70 (2000). This paper is an excellent comprehensive review on complexity of human cancer.
5. van Noesel, M.M. and Versteeg, R. Pediatric neuroblastomas: Genetic and epigenetic "danse macabre." Gene 325, 1-15 (2004).
6. Boatright, K.M. and Salvesen, G.S. Mechanisms of caspase activation. Curr. Opin. Cell Biol. 15, 725-731 (2003). This paper is a great overview of apoptotic pathways focusing on mechanisms of caspase activation, and introducing proximity-induced dimerization as a distinct mechanism for activation of initiator caspases.
7. Kruidering, M. and Evan, G.I. Caspase-8 in apoptosis: The beginning of "the end"? IUBMB Life 50, 85-90 (2000).
8. Teitz, T., Lahti, J.M., and Kidd, V.J. Aggressive childhood neuroblastomas do not express caspase-8: An important component of programmed cell death. J. Mol. Med. 79, 428-436 (2001). This paper reported that the re-introduction of caspase-8 re-sensitizes neuroblastoma cells to apoptosis, and suggested caspase-8 is a tumor suppressor.
9. Teitz, T., Wei, T., Valentine, M.B. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat. Med. 6, 529-35 (2000). This paper was first to report that caspase-8 gene is silenced in neuroblastoma through DNA methylation or gene deletion.
10. Stupack, D.G., Teitz, T., Potter, M.D., Mikolon, D., Houghton, P.J., Kidd, V.J., Lahti, J.M., and Cheresh, D.A. Potentiation of neuroblastoma metastasis by loss of caspase-8. Nature 439, 95-99 (2006).
11. Zijlstra, A., Mellor, R., Panzarella,G., Aimes, R.T., Hooper, J.D., Marchenko, N.D., and Quigley, J.P. A quantitative analysis of rate-limiting steps in the metastatic cascade using human-specific real-time polymerase chain reaction. Cancer Res. 62, 7083-7092 (2002).
12. Tufan, A.C. and Satiroglu-Tufan, N.L. The chick embryo chorioallantoic membrane as a model system for the study of tumor angiogenesis, invasion and development of anti-angiogenic agents. Curr. Cancer Drug Targets 5, 249-66 (2005).
13. Ossowski, L. In vivo invasion of modified chorioallantoic membrane by tumor cells: The role of cell surface-bound urokinase. J. Cell Biol. 107 (6 Pt 1), 2437-2445 (1988).
14. Beltinger, C. and Debatin, K.M. Murine models for experimental therapy of pediatric solid tumors with poor prognosis. Int. J. Cancer 92, 313-318 (2001).
15. Chambers, A.F., Shafir, R., and Ling, V., A model system for studying metastasis using the embryonic chick. Cancer Res. 42, 4018-4025 (1982).
16. Ossowski, L. and Reich, E. Experimental model for quantitative study of metastasis. Cancer Res. 40, 2300-2309 (1980). This is the original paper introducing the CAM model as a system to study metastasis.
17. MacDonald, I.C., Schmidt, E.E., Morris, V.L., Chambers, A.F., and Groom, A.C. Intravital videomicroscopy of the chorioallantoic microcirculation: A model system for studying metastasis. Microvasc Res. 44, 185-99 (1992).
18. Kim, J., Yu, W., Kovalski, K., and Ossowski, L. Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay. Cell 94, 353-362 (1998). This paper was first to report a PCR amplification of human alu sequences in combination with the CAM system as a tool to semiquantitatively assess metastasis.
19. Fulda, S., Kufer, M.U., Meyer, E., van Valen, F., Dockhorn-Dworniczak, B., and Debatin, K.M. Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer. Oncogene 20, 5865-5877 (2001).
20. Teitz, T., Wei, T., Liu, D., Valentine, V., Valentine, M., Grenet, J., Lahti, J.M., and Kidd, V.J.Caspase-9 and Apaf-1 are expressed and functionally active in human neuroblastoma tumor cell lines with 1p36 LOH and amplified MYCN. Oncogene 21, 1848-1858 (2002).
21. Frisch, S.M. and Francis, H. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 124, 619-626 (1994). This is the first paper to introduce phenomenon of "anoikis."
22. Stupack, D.G., Puente, X.S., Boutsaboualoy, S., Storgard, C.M., and Cheresh, D.A. Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins. J. Cell Biol. 155, 459-470 (2001). This is among the first papers to suggest integrins as dependence receptors and to reveal their role as proactive mediators of cell death.
23. Kim, S., Bakre, M., Yin, H., and Varner, J.A. Inhibition of endothelial cell survival and angiogenesis by protein kinase A. J. Clin. Invest. 110, 933-941 (2002).
24. Jin, H. and Varner, J. Integrins: Roles in cancer development and as treatment targets. Br. J. Cancer 90, 561-565 (2004).
25. 3 integrin regulates osteoclast apoptosis by transmitting a positive death signal. Mol. Endocrinol. 19, 771-780 (2005).
26. Aoudjit, F. and Vuori, K. Integrin signaling inhibits paclitaxel-induced apoptosis in breast cancer cells. Oncogene 20, 4995-5004 (2001).
27. Fujita, S., Watanabe, M., Kubota, T., Teramoto, T., and Kitajima, M. Alteration of expression in integrin beta 1-subunit correlates with invasion and metastasis in colorectal cancer. Cancer Lett. 91, 145-149 (1995).
28. Sethi, T., Rintoul, R.C., Moore, S.M. Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: A mechanism for small cell lung cancer growth and drug resistance in vivo. Nat. Med. 5, 662-668 (1999).
29. Park, C.C., Zhang, H., Pallavicini, M., Gray, J.W., Baehner, F., Park, C.J., and Bissell, M.J. Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo. Cancer Res. 2006. 66, 1526-1535 (2006).
30. Favrot, M.C., Combaret, V., Goillot, E. et al. Expression of integrin receptors on 45 clinical neuroblastoma specimens. Int. J. Cancer 49, 347-355 (1991).
31. Meyer, A., van Golen, C.M., Kim, B., van Golen, K.L., and Feldman, E.L. Integrin expression regulates neuroblastoma attachment and migration. Neoplasia 6, 332-342 (2004).
32. Schwartz, M.A. Integrins, oncogenes, and anchorage independence. J. Cell Biol. 139, 575-578 (1997).
33. Stupack, D.G. Integrins as a distinct subtype of dependence receptors. Cell Death Differ. 12, 1021-1030 (2005).
34. Poulaki, V., Mitsiades, M., Romero, M.E., and Tsokos, M. Fas-mediated apoptosis in neuroblastoma requires mitochondrial activation and is inhibited by FLICE inhibitor protein and Bcl-2. Cancer Res. 61, 4864-4872 (2001).
35. Marconi, A., Atzei, P., Panza, C. Fila, C., Tiberio, R., Truzzi, F., Wachter, T., Leverkus, M., and Pincelli, C. FLICE/caspase-8 activation triggers anoikis induced by beta1-integrin blockade in human keratinocytes. J. Cell Sci. 117(Pt 24), 5815-5823 (20040.
36. Kim, P.K., Mahidhara, R., and Seol, D.W. The role of caspase-8 in resistance to cancer chemotherapy. Drug Resist. Update 4, 293-296 (2001).
37. 2+/calmodulin-dependent protein kinase IV. J. Cell Biochem. 95, 1214-1223 (2005).
38. Goldsmith, K.C. and Hogarty, M.D. Targeting programmed cell death pathways with experimental therapeutics: Opportunities in high-risk neuroblastoma. Cancer Lett. 228, 133-141 (2005).